yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39681190-18E7FBF5-11C2-44FF-86BF-302B9538B14D
Q39681190-18E7FBF5-11C2-44FF-86BF-302B9538B14D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39681190-18E7FBF5-11C2-44FF-86BF-302B9538B14D
The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews.
P2860
Q39681190-18E7FBF5-11C2-44FF-86BF-302B9538B14D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39681190-18E7FBF5-11C2-44FF-86BF-302B9538B14D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a9b4f5766232bb9e3e513a2ef0b48378db63a61
P2860
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.